rosiglitazone has been researched along with Edema in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 30 (73.17) | 29.6817 |
| 2010's | 11 (26.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck-Nielsen, H; Brøsen, K; Christensen, MM; Feddersen, S; Stage, TB | 1 |
| Alam, Y; Batz, F; Fu, Y; Gerasimova, M; Hummler, E; Kuczkowski, A; Ronzaud, C; Sanders, PW; Vallon, V | 1 |
| Carmosino, M; Gerbino, A; Mastrofrancesco, L; Milano, S; Nicoletti, MC; Procino, G; Svelto, M | 1 |
| Chan, EW; Choi, NK; Griffiths, J; Kimura, M; Kimura, T; Kubota, K; Lai, EC; Man, KK; Nguyen, TA; Ooba, N; Park, BJ; Pratt, NL; Roughead, EE; Sato, T; Shin, JY; Wang, T; Wong, IC; Yang, YH | 1 |
| Lasaridis, AN; Sarafidis, PA; Stafylas, PC | 1 |
| Bernene, J; Bower, B; Hanks, S; Holford, TR; Kocherla, M; Petit, WA; Ruaño, G; Seip, RL; Wencker, D; Windemuth, A | 1 |
| Waksman, JC | 1 |
| Maldonado-Lutomirsky, M; Niggli, M; Rosenstock, J | 1 |
| Abdel-Aleem, OS; Badr, MZ; Donahue, RR; McNamara, KC; Morgenweck, J; Taylor, BK | 1 |
| Anand, S; Bailey, SD; Diaz, R; Do, R; Engert, JC; Gerstein, HC; Keavney, B; Mohan, V; Montpetit, A; Xie, C; Yusuf, S | 1 |
| Alderton, C; Craft, S; Egginton, S; Gold, M; Irizarry, M; Landreth, G; Linnamägi, U; Saunders, AM; Sawchak, S; Zvartau-Hind, M | 1 |
| Abdullah, SM; Armstead, SI; Ayers, CR; de Lemos, JA; Gore, MO; Khera, A; McGavock, J; McGuire, DK; Narang, N; See, R; Snell, PG; Stream, A | 1 |
| Berthet, S; Lapeyre-Mestre, M; Montastruc, JL; Olivier, P | 1 |
| Doubova, SV; Flores-Hernández, S; Mino-León, D; Reyes-Morales, H | 1 |
| Gnudi, L; Karalliedde, J; Manoharan, D; Mohan, V; Parthasarathy, N; Subramani, P; Subramaniyam, G; Sundaramoorthy, C; Viberti, G; Viswanathan, V | 1 |
| Herrmann, A; Hesselbarth, N; Hippius, M; Hoffmann, A; Kuschel, U | 1 |
| Aleksunes, LM; Reagan, LA; Vergara, CM; Wang, F | 1 |
| Buse, JB | 1 |
| Bell, DS | 1 |
| Caputi, AP; Chatterjee, PK; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Genovese, T; Ialenti, A; Ianaro, A; Maffia, P; Patel, NS; Pisano, B; Thiemermann, C | 1 |
| Singh, N | 1 |
| Le Feuvre, C | 2 |
| Colman, PG; Hussein, Z; Nankervis, AJ; Proietto, J; Wentworth, JM | 1 |
| Herget-Rosenthal, S; Janssen, O; Kribben, A; Mann, K; Patschan, D; Philipp, T; Pietruck, F; Van, TN; Witzke, O | 1 |
| Kendall, C; Wooltorton, E | 1 |
| Rennings, AJ; Smits, P; Stewart, MW; Tack, CJ | 1 |
| Aiello, LP; Clermont, A; Della Vecchia, K; King, GL; Kondo, T; Mastumoto, M; Rask-Madsen, C; Sotiropoulos, KB; Takahashi, J; Yasuda, Y | 1 |
| Sivagnanam, G | 1 |
| Berlie, HD; Jaber, LA; Kalus, JS | 1 |
| Buckingham, R; Karalliedde, J; Lorand, D; Starkie, M; Stewart, M; Viberti, G | 1 |
| Bansal, VS; Bora, RS; Gupta, A; Khanna, V; Khattar, SK; Mittra, S; Priyadarsiny, P; Roy, S; Saini, KS; Sangle, G; Sattigeri, J; Sharma, L; Sharma, S; Tandon, R | 1 |
| Baron, MA; Dejager, S; Mills, D; Rosenstock, J; Schweizer, A | 1 |
| Lindenfeld, J; Masoudi, FA | 1 |
| Stroup, JS | 2 |
| Karalliedde, J; Viberti, GC | 1 |
| Isom, R; Kiryluk, K | 1 |
| Blasi, ER; Ecelbarger, CM; Heyen, JR; McHarg, AD; Tiwari, S | 1 |
| King, AB | 1 |
| Akarca, C; Barton, DM; Baskar, V; Buch, HN; Kamalakannan, D; Singh, BM | 1 |
6 review(s) available for rosiglitazone and Edema
| Article | Year |
|---|---|
The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality.
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Edema; Heart Failure; Humans; Pioglitazone; PPAR gamma; Risk Factors; Rosiglitazone; Secondary Prevention; Thiazolidinediones | 2009 |
Cardiovascular risk of rosiglitazone: another perspective.
Topics: Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Monitoring; Edema; Humans; Hypoglycemic Agents; Patient Selection; Risk Factors; Rosiglitazone; Thiazolidinediones; Weight Gain | 2008 |
Management of rosiglitazone-induced edema: two case reports and a review of the literature.
Topics: Body Weight; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diuresis; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Obesity; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |
[Heart, diabetes and glitazones].
Topics: Contraindications; Diabetes Mellitus, Type 2; Edema; Heart; Heart Diseases; Humans; Hypoglycemic Agents; Insulin Resistance; Rosiglitazone; Thiazolidinediones | 2004 |
[Cardiovascular effects of rosiglitazone].
Topics: Cardiovascular Diseases; Cardiovascular System; Cause of Death; Diabetes Mellitus, Type 2; Drug Monitoring; Edema; France; Heart Failure; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Morbidity; Primary Prevention; Research Design; Risk Factors; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilator Agents | 2004 |
Thiazolidinediones and the risk of edema: a meta-analysis.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Humans; Pioglitazone; Rosiglitazone; Thiazolidinediones | 2007 |
8 trial(s) available for rosiglitazone and Edema
| Article | Year |
|---|---|
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.
Topics: Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoproteins E; Cholinesterase Inhibitors; Donepezil; Drug-Related Side Effects and Adverse Reactions; Edema; Female; Genotype; Humans; Hypoglycemic Agents; Indans; Intelligence Tests; Interview, Psychological; Male; Middle Aged; Nasopharyngitis; Piperidines; PPAR gamma; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2010 |
Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment.
Topics: Aged; Biomarkers; Chi-Square Distribution; Diabetes Mellitus, Type 2; Edema; Exercise Test; Female; Heart Failure; Hematocrit; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Oxygen Consumption; Plasma Volume; Prospective Studies; Rosiglitazone; Serum Albumin; Single-Blind Method; Stroke Volume; Texas; Thiazolidinediones; Time Factors; Ventricular Function; Weight Gain | 2011 |
Effect of spironolactone and amiloride on thiazolidinedione-induced fluid retention in South Indian patients with type 2 diabetes.
Topics: Adult; Aged; Amiloride; Diabetes Mellitus, Type 2; Diuretics; Edema; Female; Humans; Male; Middle Aged; Rosiglitazone; Spironolactone; Thiazolidinediones | 2013 |
Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation.
Topics: Diabetes Mellitus; Edema; Female; Humans; Hypoglycemic Agents; Kidney Transplantation; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2005 |
Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects.
Topics: Adult; Blood Pressure; Capillary Permeability; Edema; Female; Forearm; Humans; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; omega-N-Methylarginine; Plasma Volume; Regional Blood Flow; Rosiglitazone; Thiazolidinediones; Vasodilation | 2006 |
Effect of various diuretic treatments on rosiglitazone-induced fluid retention.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Edema; Extracellular Fluid; Female; Furosemide; Hematocrit; Humans; Hydrochlorothiazide; Hypoglycemic Agents; Male; Middle Aged; Plasma Volume; Rosiglitazone; Spironolactone; Sulfonylurea Compounds; Thiazolidinediones | 2006 |
Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.
Topics: Adamantane; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Edema; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Nitriles; Pyrrolidines; Racial Groups; Rosiglitazone; Thiazolidinediones; Vildagliptin | 2007 |
A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.
Topics: Body Weight; Cholesterol, LDL; Chromans; Diabetes Mellitus, Type 2; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2000 |
27 other study(ies) available for rosiglitazone and Edema
| Article | Year |
|---|---|
The role of genetic variants in CYP2C8, LPIN1, PPARGC1A and PPARγ on the trough steady-state plasma concentrations of rosiglitazone and on glycosylated haemoglobin A1c in type 2 diabetes.
Topics: Aged; Aryl Hydrocarbon Hydroxylases; Biomarkers, Pharmacological; Cytochrome P-450 CYP2C8; Diabetes Mellitus, Type 2; Edema; Female; Genetic Association Studies; Glycated Hemoglobin; Heat-Shock Proteins; Humans; Male; Middle Aged; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphatidate Phosphatase; Polymorphism, Single Nucleotide; PPAR gamma; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2013 |
PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules.
Topics: Animals; Body Fluids; Diet, Sodium-Restricted; Edema; Epithelial Sodium Channels; Gene Knockdown Techniques; Humans; Hypoglycemic Agents; Kidney Tubules, Collecting; Male; Mice; Mice, Knockout; PPAR gamma; Rosiglitazone; Thiazolidinediones; Weight Gain | 2015 |
Rosiglitazone promotes AQP2 plasma membrane expression in renal cells via a Ca-dependent/cAMP-independent mechanism.
Topics: Aquaporin 2; Calcium Channels; Calcium Signaling; Cell Line; Cell Membrane; Cyclic AMP; Edema; Endocytosis; Epithelial Cells; Gene Expression; Heart Failure; Humans; Kidney; Rosiglitazone; Signal Transduction; Thiazolidinediones; TRPV Cation Channels; Vasopressins | 2015 |
Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries.
Topics: Databases, Factual; Edema; Ethnicity; Furosemide; Heart Failure; Hospitalization; Humans; Pioglitazone; Polymorphism, Genetic; Retrospective Studies; Rosiglitazone; Thiazolidinediones | 2015 |
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Edema; Female; Genomics; Genotype; Humans; Hypoglycemic Agents; Male; Middle Aged; Phenotype; Pioglitazone; Polymorphism, Single Nucleotide; Retrospective Studies; Rosiglitazone; Thiazolidinediones | 2009 |
Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus.
Topics: Adamantane; Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Nitriles; Pyrrolidines; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vildagliptin; Weight Gain | 2009 |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
Topics: Anilides; Animals; Benzhydryl Compounds; Brain; Central Nervous System Agents; Disease Models, Animal; Edema; Epoxy Compounds; Gene Expression; Inflammation; Male; Pain; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord; Thiazolidinediones | 2010 |
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Topics: Diabetes Mellitus, Type 2; Edema; Female; Humans; Hypoglycemic Agents; Male; NFATC Transcription Factors; Polymorphism, Single Nucleotide; Ramipril; Rosiglitazone; Thiazolidinediones | 2010 |
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Databases, Factual; Diabetes Mellitus, Type 2; Edema; Female; France; Heart Failure; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Pioglitazone; Rosiglitazone; Thiazolidinediones | 2011 |
Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico.
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Drug Combinations; Edema; Female; Follow-Up Studies; Glyburide; Humans; Hypoglycemic Agents; Male; Medication Adherence; Metformin; Mexico; Middle Aged; Pharmacovigilance; Prospective Studies; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain | 2012 |
[Severe electrolyte imbalance and edema in therapy with rosiglitazone].
Topics: Chemical and Drug Induced Liver Injury; Contraindications; Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Water-Electrolyte Imbalance | 2002 |
Glitazones and heart failure: critical appraisal for the clinician.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Diuretics; Edema; Heart Failure; Humans; Hypoglycemic Agents; Insulin; Pioglitazone; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
Unilateral edema due to a thiazolidinedione.
Topics: Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Leg; Male; Middle Aged; Rosiglitazone; Thiazolidinediones | 2003 |
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase 2; Cytokines; Dinoprostone; Edema; Exudates and Transudates; Immunohistochemistry; Isoenzymes; Lipid Peroxidation; Lung; Male; Neutrophil Infiltration; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Peroxidase; Pleurisy; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tyrosine | 2004 |
Rosiglitazone and heart failure: long-term vigilance.
Topics: Aged; Diabetes Mellitus; Edema; Heart Failure; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Time Factors | 2004 |
Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real-life experience from a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Cholesterol; Diabetes Mellitus, Type 2; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pioglitazone; Retrospective Studies; Rosiglitazone; Thiazolidinediones; Triglycerides | 2004 |
Rosiglitazone (Avandia) and macular edema.
Topics: Adverse Drug Reaction Reporting Systems; Canada; Edema; Humans; Retinal Diseases; Rosiglitazone; Thiazolidinediones | 2006 |
Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain.
Topics: Adipose Tissue; Animals; Capillary Permeability; Diabetes Mellitus; Edema; Enzyme Activation; Enzyme Inhibitors; Hypoglycemic Agents; Indoles; Male; Maleimides; Mice; Mice, Knockout; Obesity; PPAR gamma; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Zucker; Receptor, Insulin; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factor A; Weight Gain | 2006 |
Rosiglitazone and macular edema.
Topics: Contraindications; Diabetes Complications; Edema; Humans; Retinal Diseases; Risk Factors; Rosiglitazone; Thiazolidinediones | 2006 |
Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema?
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Blood Glucose; Body Weight; Cell Differentiation; Edema; Epithelial Sodium Channels; Erythrocyte Count; Fatty Acids; Glycine; Hemoglobins; Kidney; Mice; Mice, Inbred Strains; Oxazoles; PPAR alpha; PPAR gamma; RNA, Messenger; Rosiglitazone; Sodium; Sodium-Potassium-Exchanging ATPase; Thiazolidinediones; Transcriptional Activation | 2007 |
Fluid retention with thiazolidinediones: does the mechanism influence the outcome?
Topics: Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Rosiglitazone; Systole; Thiazolidinediones; Ventricular Function, Left; Water-Electrolyte Balance | 2007 |
Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Fenofibrate; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Rosiglitazone; Thiazolidinediones | 2007 |
Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Fenofibrate; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Rosiglitazone; Safety; Thiazolidinediones | 2007 |
Thiazolidinediones and fluid retention.
Topics: Aged; Blood Volume; Diabetes Mellitus, Type 2; Edema; Female; Heart Failure; Humans; Hypoglycemic Agents; Kidney; Rosiglitazone; Thiazolidinediones | 2007 |
Thiazolidinedione-induced edema in patients with heart failure.
Topics: Diabetes Mellitus, Type 2; Edema; Heart Failure; Humans; Hypoglycemic Agents; Risk Assessment; Rosiglitazone; Thiazolidinediones | 2007 |
Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.
Topics: Adiponectin; Animals; Aquaporin 2; Blood Pressure; Edema; Epithelial Sodium Channels; Insulin; Kidney; Male; Natriuresis; Oxazoles; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Triazoles; Water-Electrolyte Balance | 2008 |
Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes.
Topics: Adult; Aged; Body Mass Index; Body Weight; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |